Improving HIV prevention and care for adolescents and young adults in Uganda
Official title: Implementation Science to Understand and Design Stakeholder Informed Innovative Interventions to Improve Adolescent and Youth HIV Prevention and Care Continuums in Rural and Urban Uganda
Funded at Mu-Jhu Care · NIH-11177784 · Data updated 2026-11-12
This project will try offering long-acting HIV prevention injections and youth-focused care to help 15–24-year-olds in Uganda prevent HIV and reach viral suppression if they are living with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mu-Jhu Care NIH-funded |
| Lab location | 1 site (Kampala, Uganda) |
| Project start | September 8, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $364,997 |
| NIH project number | 5UG1HD113241-03 |
| Project ID | NIH-11177784 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are adolescents and young adults (about 15–24 years old) in Uganda who are at high risk for HIV or are living with HIV and need better support to stay on prevention or treatment.
✕Less likely to help
People outside the 15–24 age range, those not living in participating communities or clinics in Uganda, or individuals with medical reasons that prevent use of cabotegravir may not benefit from this project.
What this research studies
You would be part of work that reaches young people in both rural and urban communities across Uganda to find those at higher risk for HIV and connect them to services. For HIV-negative youth, the project will offer long-acting injectable PrEP (cabotegravir) through community-friendly delivery models to reduce the need for daily pills. For youth living with HIV, teams will provide life-stage based support and the SEARCH-Youth package to help improve treatment adherence and viral suppression. The program uses proven interventions in combination with new screening approaches and implementation methods to make services easier for young people to use.
Why it matters
Potential benefit: If successful, the work could make prevention and treatment easier for young people and increase protection against HIV and rates of viral suppression.
How similar studies have gone: Long-acting injectable PrEP has shown strong protection in clinical trials, but delivering it and combining it with youth-focused support in real-world Ugandan settings is newer and less tested.
Where this research is happening
-
Mu-Jhu Care
Kampala, Uganda Active
Researchers
- Principal investigator: Musoke, Philippa — Mu-Jhu Care
- Study coordinator: Musoke, Philippa
Related research
Other NIH-funded projects on the same topics.
-
Making HIV prevention and care easier for Ugandan youth
A Ugandan study is testing ways to help adolescents and young adults (15–24) prevent HIV and stay healthy, using long-acting PrEP and youth-friendly services.
-
Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
A Ugandan research team is testing practical, youth-focused strategies to help 15-24 year-olds using HIV prevention or treatment services stay healthy and engaged in care.
-
Improving HIV Prevention and Care for Ugandan Adolescents and Young Adults
A Uganda-based research effort aims to boost HIV prevention and care outcomes for 15-24 year-olds by testing practical, community-based strategies to increase PrEP use and viral suppression.
-
Adolescent and Youth HIV Prevention and Care Improvements in Uganda
A UG1 grant is testing ways to help Ugandan teens and young adults (ages 15-24) prevent HIV and stay healthy if they have HIV, using new long-acting PrEP and community care approaches.
-
Malkia Klabu: safer, youth-friendly pharmacies to boost HIV prevention for AGYW in Tanzania
A Tanzania-based project tests a youth-friendly pharmacy model to improve access to HIV prevention and sexual health services for adolescent girls and young women.
-
Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
A Ugandan study tests new ways to help teens and young adults (ages 15–24) prevent HIV and stay healthy if they are living with HIV, using community-based options and long-acting PrEP.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.